IN order to elucidate further the possible role of specific cytokines in the pathogenesis of atopic dermatitis (AD) the in vitro production of interleukin 4 (IL-4) and interferon-gamma (IFN-/) in patients with severe atopic dermatitis (n 4) was compared with that in a group of non-atopic healthy controls. Overall IL-4 production by PHA-and PWM-driven PBMNCs was increased in controls during the first 48 h in culture. Addition of interleukin 2 (IL-2) into parallel cultures generated an insignificant (p > 0.05) increase in IL-4 production in AD patients compared with that from controls. IFN-y production by PWM-stimulated PBMNCs was markedly decreased in AD patients compared with controls (p < 0.01). Addition of IL-2 (250 U/ml) to parallel cultures failed to restore IFN-y production in AD patients. Finally, no IL-4 or IFN-y activity could be detected in any of the sera. In conclusion, the data suggest a possible dysregulation of cytokine production in at least a subgroup of AD patients, with an impaired capacity to secrete IFN-y, but a partially intact IL-4 generating capacity.
Introduction
Although atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disorder first described as a disease entity in the early decades of 
